Showing results (21-30 of 26) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Plos One|December 1, 2017
Development of effective tumor immunotherapy using a novel dendritic cell-targeting Toll-like receptor ligandNadeeka H De Silva, Takashi Akazawa, Viskam Wijewardana, et al.The Journal of Antimicrobial Chemotherapy|February 10, 2023
Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2 in vitro and in vivoTakayuki Kuroda, Haruaki Nobori, Keita Fukao, et al.Journal of Medicinal Chemistry|July 5, 2025
Discovery of the Clinical Candidate S-892216: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19Yuto Unoh, Keiichiro Hirai, Shota Uehara, et al.Journal of Medicinal Chemistry|March 30, 2022
Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19Yuto Unoh, Shota Uehara, Kenji Nakahara, et al.Journal of Medicinal Chemistry|May 3, 2013
Indazole-based potent and cell-active Mps1 kinase inhibitors: rational design from pan-kinase inhibitor anthrapyrazolone (SP600125)Ken-ichi Kusakabe, Nobuyuki Ide, Yataro Daigo, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Diaminopyridine-based potent and selective mps1 kinase inhibitors binding to an unusual flipped-Peptide conformationKen-Ichi Kusakabe, Nobuyuki Ide, Yataro Daigo, et al.Pageof 3